Status:
COMPLETED
Acupuncture Combined With Nimodipine for Prevention of Post-stroke Dementia
Lead Sponsor:
Yuzhen Pan
Collaborating Sponsors:
Department of acupuncture and massage, Nanling Hospital of traditional Chinese Medicine, Nanling County, Wuhu City, Anhui Province
Conditions:
Post-stroke Dementia
Eligibility:
All Genders
40-85 years
Phase:
NA
Brief Summary
To observe the clinical efficacy of TCM acupuncture combined with western medicine nimodipine for prevention of post-stroke dementia by comparing with clinical conventional treatment methods.
Eligibility Criteria
Inclusion
- Definite ischemic stroke or hemorrhagic stroke confirmed by head CT / MRI examination
- Memory or cognitive and executive dysfunction. Cognitive dysfunction will be determined after the mini mental state evaluation (MMSE) score
- Age limited to 40-85 years, irrespective of gender
- Stable condition, clear consciousness, no aphasia, oral medication available
- No major comorbidity, no major depression
- Consent and signed patient informed consent
Exclusion
- Had serious medical conditions, such as heart, liver, kidney, or endocrine disease
- Aphasia or hearing impairment
- Participants in other clinical trials
- Patients currently on medication to improve cognitive function
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 15 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06007573
Start Date
February 1 2021
End Date
August 15 2023
Last Update
August 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Second Affiliated Hospital of Anhui University of Chinese Medicine
Hefei, Anhui, China, 230031